← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity

NNOX logoNano-X Imaging Ltd.(NNOX)Earnings, Financials & Key Ratios

NNOX•NASDAQ
$1.79
$117M mkt cap·Price updated May 6, 2026
SectorHealthcareIndustryMedical DevicesSub-IndustryImaging, radiation, and oncology devices
AboutNano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode. The company develops a prototype of the Nanox.ARC, a medical imaging system incorporating its digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that would allow for the delivery of medical screening as a service. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists to provide, as well as customers to obtain remote interpretations of imaging data; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data included in images of existing computed tomography scans for osteoporosis and cardiovascular disease; Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities; and multi-specialty physician groups, contracts, and radiology readings. The company was founded in 2011 and is headquartered in Neve Ilan, Israel.Show more
  • Revenue$11M+13.9%
  • EBITDA-$45M+11.4%
  • Net Income-$54M+11.9%
  • EPS (Diluted)-0.91+15.7%
  • Gross Margin-94.03%-41.3%
  • EBITDA Margin-398.95%+22.2%
  • Operating Margin-502.93%+20.4%
  • Net Margin-474.31%+22.7%
  • ROE-27.83%+3.8%
  • ROIC-27.93%-0.7%
  • Debt/Equity0.04-8.3%
Technical→

NNOX Key Insights

Nano-X Imaging Ltd. (NNOX) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Company is almost debt free
  • ✓Trading at only 0.6x book value

✗Weaknesses

  • ✗Negative free cash flow
  • ✗Weak momentum: RS Rating 7 (bottom 7%)
  • ✗Trading more than 30% below 52-week high
  • ✗Low asset turnover indicates capital-intensive operations

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

NNOX Price & Volume

Nano-X Imaging Ltd. (NNOX) stock price & volume — 10-year historical chart

Loading chart...

NNOX Growth Metrics

Nano-X Imaging Ltd. (NNOX) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years-
3 Years105.3%
TTM15.19%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM-12.08%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM-3.53%

Return on Capital

10 Years-31.81%
5 Years-31.81%
3 Years-32.33%
Last Year-28.43%

NNOX Recent Earnings

Nano-X Imaging Ltd. (NNOX) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 3/12 qtrs (27%)●Beat Revenue 0/12 qtrs (0%)
Q2 2026Latest
Apr 20, 2026
EPS
$0.50
Est $0.23
-117.4%
Revenue
$4M
Est $4M
-12.5%
Q4 2025
Nov 20, 2025
EPS
$0.65
Est $0.15
-333.3%
Revenue
$3M
Est $4M
-13.7%
Q3 2025
Aug 12, 2025
EPS
$0.23
Est $0.17
-31.4%
Revenue
$3M
Est $4M
-13.3%
Q2 2025
May 22, 2025
EPS
$0.21
Est $0.19
-10.5%
Revenue
$3M
Est $3M
-17.2%
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestApr 20, 2026
$0.50vs $0.23-117.4%
$4Mvs $4M-12.5%
Q4 2025Nov 20, 2025
$0.65vs $0.15-333.3%
$3Mvs $4M-13.7%
Q3 2025Aug 12, 2025
$0.23vs $0.17-31.4%
$3Mvs $4M-13.3%
Q2 2025May 22, 2025
$0.21vs $0.19-10.5%
$3Mvs $3M-17.2%
Based on last 12 quarters of dataView full earnings history →

NNOX Peer Comparison

Nano-X Imaging Ltd. (NNOX) competitors in Imaging, radiation, and oncology devices — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
HOLO logoHOLOMicroCloud Hologram Inc.Direct Competitor2.56M1.76-0.2842.62%91.92%10.3%0.00
ATEC logoATECAlphatec Holdings, Inc.Direct Competitor1.06B6.99-7.2824.95%-21.07%-141.88%17.21
PRCT logoPRCTPROCEPT BioRobotics CorporationDirect Competitor1.41B24.80-14.4237.22%-31.82%-27.7%0.14
GEHC logoGEHCGE HealthCare Technologies Inc.Product Competitor28.08B61.7413.574.84%7.54%14.45%0.94
SYK logoSYKStryker CorporationProduct Competitor111.96B292.3334.8011.16%12.92%15.04%0.66
ISRG logoISRGIntuitive Surgical, Inc.Product Competitor160.44B451.7357.4020.51%28.15%16.89%0.02
MMSI logoMMSIMerit Medical Systems, Inc.Product Competitor3.68B61.6328.9311.66%9.03%8.95%0.57
MDT logoMDTMedtronic plcSupply Chain99.48B77.6021.503.62%13%9.45%0.59

Compare NNOX vs Peers

Nano-X Imaging Ltd. (NNOX) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs HOLO

Most directly comparable listed peer for NNOX.

Scale Benchmark

vs NVDA

Larger-name benchmark to compare NNOX against a more recognizable public peer.

Peer Set

Compare Top 5

vs HOLO, ATEC, PRCT, GEHC

NNOX Income Statement

Nano-X Imaging Ltd. (NNOX) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
Line itemDec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24TTM
Sales/Revenue0001.3M8.58M9.9M11.28M12.3M
Revenue Growth %----557.82%15.47%13.91%15.19%
Cost of Goods Sold35K53K208K2.82M15.46M16.5M21.89M24.46M
COGS % of Revenue---215.95%180.21%166.55%194.03%-
Gross Profit
-35K▲ 0%
-53K▼ 51.4%
-208K▼ 292.5%
-1.51M▼ 626.9%
-6.88M▼ 355.0%
-6.59M▲ 4.2%
-10.61M▼ 60.9%
-12.16M▲ 0%
Gross Margin %----115.95%-80.21%-66.55%-94.03%-98.83%
Gross Profit Growth %--51.43%-292.45%-626.92%-355.03%4.19%-60.94%-
Operating Expenses1.9M22.57M43.92M60.05M72.33M56M46.14M45.63M
OpEx % of Revenue---4604.75%843.18%565.34%408.91%-
Selling, General & Admin1.23M19.85M34.71M41.74M45.63M28.39M25.75M25.67M
SG&A % of Revenue---3201.07%531.94%286.66%228.21%-
Research & Development672K2.72M9.21M17.12M26.51M26.05M20.18M19.8M
R&D % of Revenue---1313.04%309.01%262.99%178.87%-
Other Operating Expenses0001.18M191K1.55M206K162K
Operating Income
-1.9M▲ 0%
-22.57M▼ 1085.5%
-43.92M▼ 94.6%
-61.56M▼ 40.1%
-109.71M▼ 78.2%
-62.59M▲ 43.0%
-56.75M▲ 9.3%
-57.79M▲ 0%
Operating Margin %----4720.71%-1278.97%-631.89%-502.93%-469.74%
Operating Income Growth %--1085.45%-94.6%-40.15%-78.22%42.95%9.34%-
EBITDA-1.87M-22.52M-43.72M-59.27M-98.2M-50.78M-45.01M-46M
EBITDA Margin %----4544.94%-1144.77%-512.66%-398.95%-373.95%
EBITDA Growth %--1104.82%-94.13%-35.57%-65.69%48.29%11.36%-6.52%
D&A (Non-Cash Add-back)35K53K208K2.29M11.51M11.81M11.73M11.79M
EBIT-1.9M-22.57M-43.81M-61.56M-87.21M-59.66M-56.75M-56.51M
Net Interest Income08K108K-288K789K1.65M2.87M1.89M
Interest Income08K108K0789K1.65M2.87M2.04M
Interest Expense5K00288K000149K
Other Income/Expense-5K8K108K-288K-14.67M1.47M2.87M1.89M
Pretax Income
-1.91M▲ 0%
-22.56M▼ 1081.9%
-43.81M▼ 94.2%
-61.85M▼ 41.2%
-108.92M▼ 76.1%
-61.12M▲ 43.9%
-53.87M▲ 11.8%
-55.9M▲ 0%
Pretax Margin %----4742.79%-1269.77%-617.01%-477.48%-454.38%
Income Tax5K00-48K-3.68M-339K-358K-192K
Effective Tax Rate %-0.26%0%0%0.08%3.38%0.55%0.66%0.34%
Net Income
-1.91M▲ 0%
-22.55M▼ 1081.5%
-43.5M▼ 92.9%
-61.8M▼ 42.1%
-105.24M▼ 70.3%
-60.78M▲ 42.3%
-53.52M▲ 11.9%
-55.71M▲ 0%
Net Margin %----4739.11%-1226.89%-613.59%-474.31%-452.82%
Net Income Growth %--1081.51%-92.86%-42.07%-70.3%42.25%11.95%-12.08%
Net Income (Continuing)-1.91M-22.56M-43.81M-61.8M-113.24M-60.78M-53.52M-55.71M
Discontinued Operations00000000
Minority Interest00000000
EPS (Diluted)
-0.06▲ 0%
-0.49▼ 776.6%
-1.22▼ 149.0%
-1.28▼ 4.9%
-2.01▼ 57.0%
-1.08▲ 46.3%
-0.91▲ 15.7%
-0.87▲ 0%
EPS Growth %--776.57%-148.98%-4.92%-57.03%46.27%15.74%-3.53%
EPS (Basic)-0.06-0.49-1.22-1.28-2.01-1.08-0.91-
Diluted Shares Outstanding34.17M45.72M35.65M48.22M52.23M56.37M58.62M64.32M
Basic Shares Outstanding34.17M45.72M35.65M48.22M52.23M56.37M58.62M64.32M
Dividend Payout Ratio--------

NNOX Balance Sheet

Nano-X Imaging Ltd. (NNOX) balance sheet — assets, liabilities & shareholders' equity

Line itemDec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24TTM
Total Current Assets1.7M9.64M219.79M94.86M82.46M88.64M78.68M51.31M
Cash & Short-Term Investments5K8.07M213.47M88.71M77.62M82.38M73.21M45.19M
Cash Only5K8.07M213.47M66.64M38.46M56.38M39.3M45.19M
Short-Term Investments00022.07M39.16M26.01M33.9M0
Accounts Receivable0001.05M977K1.48M1.8M1.94M
Days Sales Outstanding---294.1841.5754.6958.3954.47
Inventory0003.13M2.41M2.36M1.49M2.67M
Days Inventory Outstanding---405.575752.1324.8930.44
Other Current Assets006.33M1.97M1.45M1.14M1.35M739K
Total Non-Current Assets156K2.23M16.36M268.31M171.47M130.01M131.32M124.77M
Property, Plant & Equipment156K754K15.38M39.16M44.7M46.92M49.2M50.39M
Fixed Asset Turnover---0.03x0.19x0.21x0.23x0.25x
Goodwill00058.3M7.42M000
Intangible Assets000101.83M91.22M80.61M70M62.04M
Long-Term Investments0145K316K67.84M25.2M327K337K373K
Other Non-Current Assets01.34M661K1.18M2.93M2.16M11.79M48.59M
Total Assets
1.85M▲ 0%
11.87M▲ 539.9%
236.15M▲ 1889.3%
363.17M▲ 53.8%
253.93M▼ 30.1%
218.65M▼ 13.9%
210M▼ 4.0%
176.09M▲ 0%
Asset Turnover---0.00x0.03x0.05x0.05x0.06x
Asset Growth %-539.95%1889.29%53.79%-30.08%-13.9%-3.95%-18.53%
Total Current Liabilities8.24M20.26M4.48M52.75M17.07M15.52M13.97M12.39M
Accounts Payable82K475K435K3.13M3.62M3.3M2.21M1.41M
Days Payables Outstanding855.143.27K763.34406.2285.4573.0836.8329.28
Short-Term Debt00519K145K740K3.49M3.06M4.14M
Deferred Revenue (Current)01.83M0247K182K543K140K749K
Other Current Liabilities001.08M44.73M7.55M3.41M3.85M6.56M
Current Ratio0.21x0.48x49.06x1.80x4.83x5.71x5.63x5.63x
Quick Ratio0.21x0.48x49.06x1.74x4.69x5.56x5.52x5.52x
Cash Conversion Cycle---293.5413.1233.7346.4555.64
Total Non-Current Liabilities82K386K923K18.27M12.18M7.61M6.91M6.99M
Long-Term Debt0003.8M3.48M000
Capital Lease Obligations0386K923K950K398K4.04M3.64M14.62M
Deferred Tax Liabilities0007.06M3.33M2.95M2.58M9.74M
Other Non-Current Liabilities0006.05M4.57M612K695K3.25M
Total Liabilities8.24M20.65M5.4M71.02M29.25M23.13M20.88M19.38M
Total Debt0526K1.44M5.77M4.62M8.4M7.45M7.88M
Net Debt-5K-7.55M-212.03M-60.87M-33.84M-47.98M-31.86M-37.31M
Debt / Equity--0.01x0.02x0.02x0.04x0.04x0.04x
Debt / EBITDA--------0.17x
Net Debt / EBITDA-------0.81x
Interest Coverage-380.80x---213.74x----379.29x
Total Equity
-6.38M▲ 0%
-8.78M▼ 37.5%
230.75M▲ 2728.7%
292.15M▲ 26.6%
224.68M▼ 23.1%
195.51M▼ 13.0%
189.12M▼ 3.3%
156.71M▲ 0%
Equity Growth %--37.5%2728.69%26.61%-23.09%-12.98%-3.27%-18.48%
Book Value per Share-0.19-0.196.476.064.303.473.232.44
Total Shareholders' Equity-6.38M-8.78M230.75M292.15M224.68M195.51M189.12M156.71M
Common Stock58K75K131K149K158K165K181K185K
Retained Earnings-18.04M-40.6M-84.42M-146.21M-251.46M-320.23M-373.75M-415.39M
Treasury Stock00000000
Accumulated OCI-83K00-607K-1.97M-305K-1K0
Minority Interest00000000

NNOX Cash Flow Statement

Nano-X Imaging Ltd. (NNOX) cash flow — operating, investing & free cash flow history

Line itemDec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24TTM
Cash from Operations-3.67M-5.52M-21.49M-38.07M-43.38M-44.78M-36.6M-36.6M
Operating CF Margin %----2919.56%-505.77%-452.06%-324.36%-
Operating CF Growth %--50.48%-288.98%-77.18%-13.96%-3.21%18.27%-55.07%
Net Income-1.91M-22.56M-43.81M-61.8M-105.24M-60.78M-53.52M-55.71M
Depreciation & Amortization35K53K208K2.29M11.51M11.81M11.73M11.79M
Stock-Based Compensation115K16.25M24.78M18.81M18.62M6.84M7.26M3.69M
Deferred Taxes0-16.35M-25.3M-116K-3.73M-377K-377K-390.07K
Other Non-Cash Items185K16.35M25.3M-2K52.4M5.21M-572K-355.56K
Working Capital Changes-1.91M741K-2.66M2.75M-16.95M-7.48M-1.13M-1.23M
Change in Receivables000-40K74K-507K-321K-450.66K
Change in Inventory000864K00-277K-160.75K
Change in Payables-134K393K-103K1.72M469K-153K-1.32M-233.33K
Cash from Investing-73K-125K-13.94M-116.32M14.61M35.43M-20.05M5.48M
Capital Expenditures-73K-125K-13.94M-23.16M-7.17M-3.3M-2.77M-4.51M
CapEx % of Revenue---1775.92%83.6%33.35%24.52%-
Acquisitions000-2.86M1.01M000
Investments--------
Other Investing000-90.3M-1.01M-373K46K52.43K
Cash from Financing3.68M13.86M240.99M7.38M804K27.25M39.5M43.96M
Debt Issued (Net)0003.8M0000
Equity Issued (Net)1000K1000K1000K001000K1000K2.12M
Dividends Paid00000000
Share Repurchases00000000
Other Financing0-177K630K3.58M804K113K1.67M4K
Net Change in Cash
-60K▲ 0%
8.21M▲ 13786.7%
205.57M▲ 2403.3%
-147.01M▼ 171.5%
-28.24M▲ 80.8%
17.85M▲ 163.2%
-17.07M▼ 195.7%
6.99M▲ 0%
Free Cash Flow
-3.74M▲ 0%
-5.65M▼ 50.9%
-35.42M▼ 527.1%
-61.23M▼ 72.8%
-50.56M▲ 17.4%
-48.08M▲ 4.9%
-39.37M▲ 18.1%
-46.7M▲ 0%
FCF Margin %----4695.48%-589.37%-485.41%-348.89%-379.64%
FCF Growth %--50.88%-527.08%-72.85%17.43%4.9%18.13%-16.02%
FCF per Share-0.11-0.12-0.99-1.27-0.97-0.85-0.67-0.67
FCF Conversion (FCF/Net Income)1.92x0.24x0.49x0.62x0.41x0.74x0.68x0.84x
Interest Paid00013K90K149K140K102K
Taxes Paid008K7K147K3K53K186K

NNOX Key Ratios

Nano-X Imaging Ltd. (NNOX) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric201920202021202220232024TTM
Return on Equity (ROE)--39.19%-23.64%-40.73%-28.93%-27.83%-35.55%
Return on Invested Capital (ROIC)--2749.77%-36.94%-38.99%-27.75%-27.93%-27.93%
Gross Margin---115.95%-80.21%-66.55%-94.03%-98.83%
Net Margin---4739.11%-1226.89%-613.59%-474.31%-452.82%
Debt / Equity-0.01x0.02x0.02x0.04x0.04x0.04x
Interest Coverage---213.74x----379.29x
FCF Conversion0.24x0.49x0.62x0.41x0.74x0.68x0.84x
Revenue Growth---557.82%15.47%13.91%15.19%

NNOX Frequently Asked Questions

Nano-X Imaging Ltd. (NNOX) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Nano-X Imaging Ltd. (NNOX) reported $12.3M in revenue for fiscal year 2024.

Nano-X Imaging Ltd. (NNOX) grew revenue by 13.9% over the past year. This is steady growth.

Nano-X Imaging Ltd. (NNOX) reported a net loss of $55.7M for fiscal year 2024.

Dividend & Returns

Nano-X Imaging Ltd. (NNOX) has a return on equity (ROE) of -27.8%. Negative ROE indicates the company is unprofitable.

Nano-X Imaging Ltd. (NNOX) had negative free cash flow of $46.7M in fiscal year 2024, likely due to heavy capital investments.

Explore More NNOX

Nano-X Imaging Ltd. (NNOX) financial analysis — history, returns, DCA and operating performance tools

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.